Apr 03, 2026
267:248
For every 248 shares held, investors received 267. The price per share adjusted from $7910.00 to $7347.12.
The split itself did not change the total investment value.
ImmuneOncia Therapeutics Inc. (KRX:424870) operates in the Biotechnology industry.
ImmuneOncia Therapeutics Inc. company overviewImmuneOncia Therapeutics Inc.'s most recent stock split was on April 3, 2026. It was a 267-for-248 forward split, so shareholders received 267 shares for every 248 they held.
ImmuneOncia Therapeutics Inc. has split its stock once. This history records one forward split, on April 3, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In ImmuneOncia Therapeutics Inc.'s 267-for-248 split on April 3, 2026, every 248 shares became 267 shares.
ImmuneOncia Therapeutics Inc. has not announced a new split in our records. Its most recent split was on April 3, 2026, less than a year ago. Companies announce splits in advance, and any new KRX:424870 split will appear on this page.
Already premium?